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Abstract: Oxidative stress reflects a disturbance in the balance between the production and
accumulation of reactive oxygen species (ROS). ROS are scavenged by the antioxidant system,
but when in excess concentration, they can oxidize proteins, lipids, and DNA. DNA damage is
usually repaired, and the oxidized products are excreted in urine. 8-hydroxy-2-deoxyguanosine is
considered a biomarker for oxidative damage of DNA. It is needed to define background ranges for
8-OHdG, to use it as a measure of oxidative stress overproduction. We established a standardized
protocol for a systematic review and meta-analysis to assess background ranges for urinary 8-OHdG
concentrations in healthy populations. We computed geometric mean (GM) and geometric standard
deviations (GSD) as the basis for the meta-analysis. We retrieved an initial 1246 articles, included
84 articles, and identified 128 study subgroups. We stratified the subgroups by body mass index,
gender, and smoking status reported. The pooled GM value for urinary 8-OHdG concentrations in
healthy adults with a mean body mass index (BMI) ≤ 25 measured using chemical methods was
3.9 ng/mg creatinine (interquartile range (IQR): 3 to 5.5 ng/mg creatinine). A significant positive
association was observed between smoking and urinary 8-OHdG concentrations when measured by
chemical analysis. No gender effect was observed.
Keywords: oxidative stress; biomarker; 8-OHdG; systematic review; meta-analysis
1. Introduction
Oxidative stress reflects a disturbance in the balance between the production and accumulation
of reactive oxygen species (ROS), and an overproduction of ROS has negative consequences for cell
physiology [1]. When ROS concentration is in excess, oxidative damage to proteins, lipids, and DNA
occurs, thus causing structural and functional cellular changes. DNA damage is usually repaired
primarily via the base excision repair pathway, and oxidized products are excreted in urine [2].
8-hydroxy-2-deoxyguanosine (8-OHdG) is one of the most widely studied oxidized metabolites and is
considered as a biomarker for oxidative damage of DNA [3,4]. The formation of 8-OHdG by oxygen
radicals was first reported in 1984 by Kasai and Nishimura [5].
The interaction of the hydroxyl radical, the most important oxygen-free radical, with
the nucleobases of the DNA strand, such as guanine, leads to the formation of 8-OHdG [6] (Figure 1).
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Figure 1. Structure of 8-OHdG. 
Some diseases, such as cardiovascular or chronic obstructive pulmonary diseases (COPD), have 
been associated with excessive concentrations of 8-OHdG [7,8]. 8-OHdG levels also increase due to 
smoking, aging, or occupational exposure to physical, chemical, or biological substances [9,10]. 
A recent study suggested that 8-OHdG had high intraclass correlation coefficients (0.96), 
reproducible measurements, and low coefficients of variation and was the most suitable biomarker 
of oxidative stress in spot urine samples [11]. Concentrations of urinary oxidative stress biomarkers 
have been proposed as an effect biomarker to survey populations exposed to xenobiotics such as 
particulates, oxidizing agents, and lately, engineered nanomaterials [12,13]. 
Measuring urinary 8-OHdG has some advantages as it is very stable in urine [14], it is 
noninvasive, and its excretion is likely to reflect the oxidative DNA damage [15] and can be assessed 
by two main analytical techniques: mass-based methods (using either gas (GC) or liquid (LC) 
chromatography) and immunological methods. Another source of 8-OHdG in urine is DNA 
polymerase-dependent incorporation of 8-oxodGTP from the nucleotide pool [16]. Chromatographic 
methods are considered to be the gold standard; however, immunological techniques, which are less 
costly and time-consuming, are widely used because enzyme-linked immunosorbent assay (ELISA) 
kits have been developed for rapid detection and quantification of 8-OHdG [14,17]. 
A background range for 8-OHdG has been reported in different studies for healthy persons 
[11,18–20]. However, these studies reported a wider range of values, making the identification of 
background cut-off values challenging. 
Therefore, the systematic review and meta-analyses of the reported values appears the most 
appropriate approach to bypass this issue. Our objective was to assess background ranges for urinary 
8-OHdG concentrations in healthy adults. 
2. Results 
Chemical methods were used in 44 of the 128 study subgroups, and immunological techniques 
were used in 84 (Table 1). We decided to stratify the subgroups by body mass index (BMI), gender, 
and smoking status reported. 
2.1. Descriptive Results 
We retrieved 1246 articles, included 84 articles, and considered 129 study subgroups (Figure 2 
Tables 2–5) in the quantitative synthesis, which we stratified by main quantification techniques: 
immunological and chemical methods. For subgroups evaluated with the chemical methods, 31 
studies had participants with a mean BMI between 18 and 25 (14 study subgroups of nonsmokers 
and 2 study subgroups of smokers) (Figure 3, Table 2). Nine studies had participants with a mean 
BMI > 25 (three study subgroups of nonsmokers and two study subgroups of smokers) (Figure 4, 
Table 3). The mean BMI was unknown for four study subgroups. 
For subgroups analyzed with immunological techniques, 47 studies had participants with a 
mean BMI between 18 and 25 (24 study subgroups of nonsmokers, no study subgroups of smokers 
and 6 study subgroups with unknown smoking status) (Figure 5, Table 4). Twenty-six studies had 
participants with a mean BMI > 25 (13 study subgroups of nonsmokers and 6 study subgroups of 
smokers) (Figure 6, Table 5). The mean BMI was unknown for 11 study subgroups. Supplementary 
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Some diseases, such as cardiovascular or chronic obstructive pulmonary diseases (COPD), have
been associated with excessive concentrations of 8-OHdG [7,8]. 8-OHdG levels also increase due to
smoking, aging, or occupational exposure to physical, chemical, or biological substances [9,10].
A recent study suggested that 8-OHdG had high intraclass correlation coefficients (0.96),
reproducible measurements, and low coefficients of variation and was the most suitable biomarker of
oxidative stress in spot urine samples [11]. Concentrations of urinary oxidative stress biomarkers have
been proposed as an effect biomarker to survey populations exposed to xenobiotics such as particulates,
oxidizing agents, and lately, engineered nanomaterials [12,13].
Measuring urinary 8-OHdG has some advantages as it is very stable in urine [14], it is noninvasive,
and its excretion is likely to reflect the oxidative DNA damage [15] and can be assesse by two main
analytical techniques: mass-based methods (using either gas (GC) or liquid (LC) chromatography)
and immunological methods. Another source of 8-OHdG in urine is DNA polymerase-dependent
incorporation of 8-oxodGTP from the nucleotide pool [16]. Chromatographic methods are considered
to be the gold standard; however, immunological tech iques, which are less costly and ime-consuming,
are widely used because enzyme-linked immunosorbent assay (ELISA) kits have been developed for
rapid detection and quantification of 8-OHdG [14,17].
A background range for 8-OHdG has been reported in different studies for healthy
persons [11,18–20]. However, these studies reported a wider range of values, making the identification
of background cut-off values challenging.
Therefore, the systematic review and meta-analyses of the reported values appears the most
appropriate approach to bypass this issue. Our objective was to assess background ranges for urinary
8-OHdG concentrations in healthy adults.
2. Results
Chemical methods were used in 44 of th 128 study subgroups, and immunological techniques
were used in 84 (Table 1). We decided to stratify the subgroups by body mass index (BMI), gender, and
smoking status reported.
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Table 1. Summary of geometric mean urinary 8-OHdG concentrations (ng/mg creatinine) in subgroups
of healthy adult (18+ years) participants.




















(n = 14) (2.9–5.5) (n = 3) (1.9–2.8)
Smokers 22.2 Smokers 4.0










(n = 24) (5.9–21.6) (n = 13) (7.8–14.7)
Smokers NA Smokers 6.0
(n = 0) (n = 6) (5.4–7)
* Median (IQR: 25%–75%); ** Number of included study subgroups; NA: Not Available.
2.1. Descriptive Results
We retrieved 1246 articles, included 84 articles, and considered 129 study subgroups (Figure 2,
Tables 2–5) in the quantitative synthesis, which we stratified by main quantification techniques:
immunological and chemical methods. For subgroups evaluated with the chemical methods, 31 studies
had participants with a mean BMI between 18 and 25 (14 study subgroups of nonsmokers and 2 study
subgroups of smokers) (Figure 3, Table 2). Nine studies had participants with a mean BMI > 25 (three
study subgroups of nonsmokers and two study subgroups of smokers) (Figure 4, Table 3). The mean
BMI was unknown for four study subgroups.Int. J. Mol. Sci. 2020, 21, x FOR PEER REVIEW 4 of 30 
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Table 2. References for urinary 8-OHdG concentrations and computed GM (ng/mg creatinine) measured with chemical techniques in healthy (mean BMI ≤ 25 and no





















urine China 497 42.48 113 384 50% 23.72
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urine China 106 31.62 0 106 52.8% 23.79
3 ± 1.08










urine USA 17 30.7 0 17 0% 24.2
3.16 ±







urine Belgium 48 40 3 45 31.2% 24.2
10.76 ±
2.83 * 7.05–20.92 µg/g 10 1
[25] Menbaseline HPLC
spot
urine Japan 2370 60.7 0 2370 24.9% 23.6
3.7 ± 1.6
* ng/mg 4 2
[25] Womenbaseline HPLC
spot
urine Japan 4052 60.2 4052 0 4.7% 22.2
4.1 ± 1.7
* ng/mg 4 2
[26] Baselinevalue LC-MS/MS
spot
urine Taiwan 58 23.84 0 58 51.7% 24.55 2.63–11.54 4.42 µg/g 16 2
[27] Servicestaff group HPLC
spot
urine China 67 24.8 0 67 0% 23.2 1.4 0.9–1.8 µmol/mol 2 3
[28] Allpopulation HPLC
spot
urine Japan 503 42.4 209 294 27.4% 22.5 2.37–4.03 0.8–10.0 3.01 µg/g 3 1
[29] Baselinevalue HPLC
spot
urine Korea 102 55 102 0 0% 24.1
6.5 ± 3.9
* µg/g 6 2
[30] Controlgroup HPLC
spot
urine Japan 805 40.3 0 805 46.7% 23.7
3.79 ±
1.44 * ng/mg 4 1
[31] Baselinevalue GC-MS
spot
urine Singapore 24 22.8 NA NA 0% 21.6
2.02 ±










urine China 30 21.5 0 30 0% 22.8
6.3 ± 0.5
** µmol/mol 14 2

































LC–MS/MS spoturine Taiwan 131 64.9 57 74 50% 22.9 8.3–22.8 13 µg/g 13 2
[34] Malebaseline HPLC-EC
spot
urine Japan 79 47.9 0 79 0% 22.3
2.81 ±
1.07 * µg/g 3 2
[34] Femalebaseline HPLC-EC
spot
urine Japan 16 46.7 16 0 0% 20.6
3.04 ±
1.42 * µg/g 3 1
[35] Womenbaseline HPLC
spot












urine Japan 23 46.8 11 12 100% 23.6 3.02 2.24–4.07 ng/mg 5 1
[37] Controlgroup LC–MS/MS
spot
urine Taiwan 125 34.1 0 125 0% 22.8
4.1 ± 2.1
* µg/g 4 2
[38] Controlgroup HPLC-MS/MS
spot
urine China 185 40.4 124 61 0% 24.4
5.5 ± 2.2
* µg/g 6 2
[39] Controlgroup LC EC
spot
urine India 135 41.31 0 135 0% 22.38
3.57 ±
0.63 * µmol/mol 9 1
[40] Allpopulation HPLC
spot
urine Japan 6517 60.3 4064 2453 12.6% 22.7
3.9 ± 1.6





LC-MS/MS spoturine USA 12 69 6 6 0% 25
2 ± 0.2






LC-MS/MS spoturine USA 12 69 6 6 0% 25
1.8 ± 0.1
** µmol/mol 4 1
[42] Malegroup LC-MS/MS
spot
urine China 69 37.83 0 69 43.5% 24.1
4.55 ±
4.44 * µg/g 3 2






















urine China 23 38.55 23 0 0% 22.1
4.34 ±
3.85 * µg/g 3 2
[43] Controlgroup LC–MS/MS
spot
urine Taiwan 129 51.7 39 90 27.9% 24.6
4.3 ± 0.5
** ng/mg 3 3
[44] Mengroup HPLC
spot
urine Japan 196 44.4 0 196 43.9% 23.8
3.3 ± 1.1
* µg/g 3 1
[44] Womengroup HPLC
spot
urine Japan 136 40.4 136 0 2.9% 21
3.3 ± 1.1
* µg/g 3 1
* SD, ** SEM.
Table 3. References for urinary 8-OHdG concentrations measured and computed GM (ng/mg creatinine) with chemical techniques in healthy (mean BMI > 25 and no
known disease), adult (18+ years) participants.
















[45] Elderly lowexpose group LC–MS/MS
spot
urine Taiwan 71 66.36 36 35 9.9% 26.36 3.16 ± 4.07 * µg/g 3 2
[23] Placebo group HPLC withEC detection
spot
urine USA 19 31.1 0 19 0% 25.2 4.18 ± 4.78 * ng/mg 3 2
[46] Control group LC/MS/MS spoturine Taiwan 168 43.2 NA NA 34% 26.4 10.61 ± 7.77 * µmol/mol 21 2
[47] Control group HPLC spoturine China 31 38.7 0 31 19.4%
≤24 38.7%
>24 61.3% 1.0–4.0 1.3 µmol/mol 3 3
[48] Control nonsmoker group HPLC–ECD
spot
urine Turkey 19 54.8 3 16 0% 29.1 2.1 ± 1 * µg/g 2 1
[48] Controlex-smoker group HPLC–ECD
spot
urine Turkey 21 57.5 3 18 0% 27.2 2.6 ± 0.8 * µg/g 2 2
[48] Control smokergroup HPLC– ECD
spot
urine Turkey 24 51.1 4 20 100% 26.5 4.2 ± 2.8 * µg/g 3 2
[35] Smoking mengroup baseline HPLC
spot
urine Japan 40 28–57 0 40 100% 25.1 3.6–5.6 4.5 µg/g 4 1
[49] Control groupbaseline HPLC
spot
urine USA 20 39 20 0 50% 29 2.8 ± 1.7 * µg/g 2 2
* SD.
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Table 4. References for urinary 8-OHdG concentrations measured and computed GM (ng/mg creatinine) with immunological techniques in healthy (mean BMI ≤ 25
and no known disease), adult (18+ years) participants.



















urine Thailand 30 41.43 19 11 NA 22.56 4.32 ± 4.93 * µg/g 3 2
[51] Healthycontrol group
24 h
urine Thailand 30 41.43 19 11 NA 22.56 5.27 ± 2.77 * µg/g 5 2
[52] Controlgroup
spot
urine China 35 60 15 20 0% 22.9 11.9 ± 4.9 * ng/mg 11 1
[53] Controlgroup
spot
urine Korea 416 64.4 92 324 28.1% 23.7 5.06 4.55–5.62 µg/g 5 2
[54] Controlgroup
spot
urine Korea 140 68.8 32 108 65.5% 22.46 4.88 4.43–5.38 µg/g 5 1
[55] Healthyyoung group
24 h
urine Canada 12 22.8 0 12 0% 25
5333 ± 1191
* ng/g 5 1
[56] Apple groupfinal value
spot
urine China 13 62.8 3 10 0% 24.2
824.41 ±






urine China 13 64.1 3 10 0% 23
651.57 ±













urine China 145 48.9 87 58 33.8% 24.5
55.48 ± 1.74






urine China 143 48.66 94 49 30.1% 24.6
55.81 ± 1.72
* 54.73 ng/mg 56 2
[58] Controlgroup
24 h
urine Japan 15 40 6 9 0% 23.2 9.7 ± 4.6 * ng/mg 9 2
[59] Controlgroup I
spot
urine China 20 25.55 17 3 0% 19.74
10.68 ± 1.07
** ng/mg 10 2
[59] Controlgroup II
spot
urine China 20 24.5 15 5 0% 20.09
11.96 ± 0.73
** ng/mg 12 1
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[60] Male group spoturine Japan 195 41.7 0 195 49.7% 23.6 9.35 ± 3.66 * ng/mg 9 1
[60] Femalegroup
spot
urine Japan 194 41.7 194 0 29.9% 22.1 10.97 ± 5 * ng/mg 10 2
[61] Non MSgroup
spot
urine Japan 638 40.8 385 253 27.3% 22.3 9.28 ± 4.15 * ng/mg 8 2
[62] Male control spoturine Pakistan 34 39.7 0 34 0% 19.85 24.5 ± 6.6 * 11.08–33.8525.72 ng/mg 26 1
[62] Femalecontrol
spot
urine Pakistan 32 39.52 32 0 0% 20.83 24.5 ± 6.33 * 11.1–33.8524.47 ng/mg 24 1
[63] Controlgroup
spot
urine Pakistan 34 39.7 0 34 0% 20.9 24 ± 4 * 9–30 25 ng/mg 25 1
[64] Controlgroup
spot
urine Pakistan 34 37 0 34 0% 20.8 25.8 ± 7 * 9.1–33.9 27.9 ng/mg 28 1
[65] Pregnantwomen
spot






urine UK 32 31.7 15 17 0% 22.4 21.6 ± 12.6 * ng/mg 19 2
[66] Test groupbaseline
spot
urine UK 32 31.7 15 17 0% 22.4 24 ± 13.3 * ng/mg 21 2
[67] Controlgroup
spot
urine Turkey 20 40.7 10 10 NA 22.52 7.84 ± 7.04 * ng/mg 6 2
[68] Controlgroup
spot
urine Japan 108 23 0 108 NA 22.5 10.4 ± 3.2 * ng/mg 10 1
[69] Non exposedgroup
spot
urine Iran 43 35.58 0 43 21% 19–24
54.16 ±
26.98 * ng/mg 48 2
[70] Controlgroup
spot
urine Japan 52 62.4 27 25 0% 24 8.8 ± 0.5 ** ng/mg 8 1
[71] Male group spoturine Japan 276 42.1 0 276 NA 23.8 8.8 ± 0.2 ** ng/mg 8 1
[71] Femalegroup
spot
urine Japan 445 42.7 445 0 NA 21.9 9.8 ± 0.2 ** ng/mg 9 2
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urine Japan 136 43.4 136 0 52.2% 23.8 9.4 ± 3.4 * ng/mg 9 1
[73] Controlgroup
spot
urine USA 43 32.6 43 0 0% 23.2 6.31 ± 2.49 * ng/mg 6 1
[74] Male group spoturine Japan 323 42 0 323 42.7% 23.7 8.85 ± 3.29 ng/mg 8 1
[74] Femalegroup
spot


















urine Japan 8 21.1 0 8 0% >18 <25 22.9 ± 7.9 * ng/mg 22 1
[75] Placebogroup
spot
urine Japan 8 21.1 0 8 0% >18 <25 18 ± 6.2 * ng/mg 17 1
[76] Men group spoturine Japan 272 43.5 0 272 60.7% 23.7 8.86 ± 3.36 * 2.13–21.87 µg/g 8 1
[76] Womengroup
spot












urine China 34 47.9 34 0 0% 23.2 12.7 ± 4.7 *
2.60,
25.8 13.6 ng/mg 9 2
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urine Turkey 30 69.1 20 10 0% 23.6 5.74 ± 2.68 * ng/mg 5 2
[80] Baselinevalue
spot
urine China 25 20.9 12 13 0% 20.67
3765.63 ±
958.14 * ng/mmol 32 1
[15] Womengroup
spot
urine Italy 33 30 33 0 29% 20.7 3.68–7.20 5.21 ng/mg 4 2
[81] Non exposedgroup
spot
urine China 143 27.89 100 43 8% 21.03
17.36 ± 13.5
* ng/mg 14 2
* SD; ** SEM.
Table 5. References for urinary 8-OHdG concentrations measured and computed GM (ng/mg creatinine) with immunological techniques in healthy (mean BMI > 25
and no known disease), adult (18+ years) participants.














[82] Cocoritcommunities spot urine Mexico 10 45.9 5 5 30% 27 8.2 ± 4.3 * µg/g 7 2
[82] Pueblo Yaquicommunities spot urine Mexico 15 35.3 9 6 7% 26.7 5.7 ± 2.9 * µg/g 5 2
[82] Campo 47 spot urine Mexico 15 39.5 10 5 40% 29.8 5.7 ± 3.3 * µg/g 5 2
[83] Control group spot urine UK 61 28.4 61 0 9% 26 39.83 ±2.92 ** ng/mg 35 2
[55] Healthy oldergroup 24 h urine Canada 12 71.8 0 12 0% 28.8
7714 ±
1402 * ng/g 8 1
[84] Water groupbaseline value spot urine USA 42 18–79 32 10 100% 25.9
8.7 ± 1.3
** ng/mg 5 3
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[84] Green tea groupbaseline value spot urine USA 35 18–79 27 8 100% 26.5
10.8 ± 1.3
** ng/mg 9 2
[84] Black teabaseline value spot urine USA 43 18–79 31 12 100% 26.7
9.5 ± 2.1
** ng/mg 6 2
[85] Water groupbaseline value spot urine USA 45 49.8 32 13 100% 26.9
9.5 ± 1.3
** ng/mg 6 3
[85] Black teabaseline value spot urine USA 46 52.1 34 12 100% 27.2
10.8 ± 2.5
** ng/mg 7 2
[85] Green tea groupbaseline value spot urine USA 42 51.6 32 10 100% 27.2
8.7 ± 1.8
** ng/mg 5 3
[86] Placebo groupbaseline value 24 h urine USA 47 58.1 23 24 0% 28.9
17.6 ±
10.4 * ng/mg 15 2
[86] Vit C groupbaseline value 24 h urine USA 46 61.2 26 20 0% 28.7
19.3 ± 9.3
* ng/mg 17 2
[86] Vit E groupbaseline value 24 h urine USA 45 55.5 29 16 0% 28.6
16.5 ± 8.4
* ng/mg 15 2
[86] Vit C + Vit Ebaseline value 24 h urine USA 46 57.7 24 22 0% 28.9
17.7 ± 9.5
* ng/mg 16 2
[87] Control group 24 h urine Finland 100 65 46 54 18% 27.7 24.3 ±15.2 * ng/mg 21 2
[88] Control group spot urine Taiwan 27 49 0 27 55.6% 25.8 5 ± 4.92 * µg/g 4 2
[89] All population spot urine Japan 90 52 60 30 0% 25.2 5.8–23.2 0.90–48.0 9.3 ng/mg 9 3
[90] Baseline value spot urine Canada 28 68.5 NA NA 0% 27.1 10783 ±5856 * ng/g 9 2
[91] control groupbaseline spot urine Spain 23 30.42 23 0 0% 25.32
9.29 ±
0.69 ** ng/mg 9 1
[91] DHA groupbaseline spot urine Spain 23 29.97 23 0 0% 25.62
9.81 ±
0.79 ** ng/mg 9 1
[92] Placebo groupmen 24 h urine Canada 8 74.8 0 8 0% 25.9
8329 ±
3032 * ng/g 8 1
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[92] Placebo groupwomen 24 h urine Canada 10 68.3 10 0 0% 25.2
11622 ±










24 h urine Canada 10 69.5 10 0 0% 25.5 7942 ±3071 * ng/g 7 1
[15] Men group earlymorning spot urine Italy 22 34 0 22 38.1% 25.3 2.76–5.25 3.76 ng/mg 5 2
* SD; ** SEM.
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For subgroups analyzed with immunological techniques, 47 studies had participants with a mean
BMI between 18 and 25 (24 study subgroups of nonsmokers, no study subgroups of smokers and 6 study
subgroups with unknown smoking status) (Figure 5, Table 4). Twenty-six studies had participants with
a mean BMI > 25 (13 study subgroups of nonsmokers and 6 study subgroups of smokers) (Figure 6,
Table 5). The mean BMI was unknown for 11 study subgroups. Supplementary material provides
detailed information on the criteria used for the quality assessment (S1) and on the quality level of
each included study subgroup (S2). Overall, two study subgroups (1.8%) were classified as low quality,
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2.2. Meta-Analysis Results
As between-study heterogeneity was much larger than the between-subject heterogeneity, we
decided to use a mixed model with study ID as a random effect. The IQR of subgroup-specific GM in
subgroups with a mean BMI ≤ 25 with 8-OHdG measured using chemical methods was 3 to 5.5 ng/mg
creatinine (Table 1). IQR of subgroup-specific GM in subgroups with a mean BMI > 25 measured using
immunological methods was 5.9 to 19.8 ng/mg creatinine (Table 1).
We compared uri r - c centrations by smoking status within the study subgroups
analyzed with che ical t i f that for study subgroups with mean BMI ≤ 25, smokers
were 2.84 ([2.56, 3.16], p ) ti es greater compared to nonsmoker study subgroups.
For study subgroups it 25, smokers were 1.61 ([ .17, .23], p = .004) times gr ater
compared to the no s
No consistent effects of B I and gender ere s r i i l it i l or
immunological methods. Gender and BMI seem to not influence urinary 8-OHd co ce trati s.
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3. Discussion
3.1. Interpretation of Findings
We found that urinary 8-OHdG concentrations in smokers were greater than in nonsmokers
when analysis was conducted with chemical techniques. However, in the population with mean
BMI between 18 and 25, this finding was mainly due to one study [32] and needs to be confirmed.
The absence of BMI effect on 8-OHdG in urine is in line with data from Lee et al. 2010 [93].
The IQR range for 8-OHdG in urine given in this meta-analysis is in line with two other studies
trying to define reference values for the Italian population (female: 3.25–6.85 ng/mg creatinine; male:
2.9–5.5 ng/mg creatinine) [94]. The absence of gender effect observed for 8-OHdG in this study is in
line with data from the Italian population [94] but in contradiction with two others [93,95].
The analysis of the data was difficult due to the diversity in study design, analytical methods
(chemical or immunoassay techniques), statistical analysis, and data presentation in studies included.
3.2. Quantification of 8-OHdG
The heterogeneity in techniques used to quantify urinary 8-OHdG makes it more difficult to
compare data between laboratories.
Chemical techniques are superior to immunological techniques due to their sensitivity and
specificity [14,96]. Chemical techniques require expensive instruments and trained users, but
we recommend using chemical quantification methods as standard methods for future studies
of biomonitoring.
3.3. Lack of Homogeneity in Data Collection and Reporting
Most studies used spot urine samples for 8-OHdG rather than 12- or 24-h collection. However,
8-OHdG levels showed fluctuation during the day under oxidative states [97], but good correlations
have been observed between levels of 8-OHdG in spot morning urine and levels of 8-OHdG in the 24-h
urinary collection [14]. Therefore, we included studies reporting spot morning urine, 12- or 24-h
urinary samples. The first morning urine void is particularly valuable because it provides a time
average for biomarker concentrations that may occur during the hours of sleep (approximately 8 h) and
is also relatively free of dietary, physical, and environmental exposures [15]. A significant increase in
time in the urinary 8-OHdG during the first part of the day was recently reported among smokers [15].
To make it easier to compare results between studies, we recommend collecting spot morning urine.
3.4. Limitations
We confirm that smokers have a significantly greater concentration of urinary 8-OHdG, as has
been previously reported in the literature. The concentration differences need to be quantified, but
with only a few studies in smokers available, this cannot be done at the present time.
We emphasize here that the values we report are for a healthy population. We were not able
to analyze parameters previously reported to influence 8-OHdG concentrations such as occupation,
pregnancy, special diet, vitamin, and physical activity due to the limited number of studies with
such data.
3.5. Recommendations
The fluctuation in urine flow rate could in fact affect the assessment of urinary 8-OHdG. The urinary
8-OHdG concentrations need to be normalized by urinary creatinine concentrations for healthy adults.
Different studies indicated a correlation between excretion of creatinine and 8-OHdG [94,95]. In
addition, normalization with creatinine for spot urine can be considered as a surrogate for the 24-h
excretion of 8-OHdG [94,98].
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To reach consensual background of urinary 8-OHdG values, harmonization of the unit (ng/mg
creatinine) is needed. Harmonization of the statistical reporting of the results is also recommended
(geometric means (GM) and geometric standard deviations (GSD)). We suggest reporting the median
and the 1st and 3rd quartile as GSDs are not easy to interpret.
4. Materials and Methods
We established a standardized protocol for systematic review and meta-analysis for a set of
biomarkers of oxidative stress. This protocol was registered in the International Prospective Register
of Systematic Reviews (registration number CRD 42020146623) [99] and described in detail by
Hemmendinger et al. [100]. The protocol was then adapted for each biomarker depending on
the biological matrix focused, here the urinary 8-OHdG. The methods and results of this study are
reported following recommendations from Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) recommendations [101,102].
4.1. Literature Search
The search strategy was done with a medical librarian. The MeSH (Medical Subject Headings)
terms from the PubMed database and free text words were combined. The complete search
string was: (“Smoking/urine”[Mesh] OR “Urine”[Mesh] OR Urine*[tiab] OR Urinary[tiab] OR
Urinal*[tiab]) AND (“8-oxo-7-hydrodeoxyguanosine”[Supplementary Concept] OR 8-OHdg[tw] OR
8ohdg[tw] OR 8-oh-dg[tw] OR 8-ohg[tw] OR 8-OH-2dG[tw] OR 8-hydroxydeoxyguanosine[tw] OR
8-hydroxyguanine[tw] OR 8-hydroxy-g[tw] OR 8-hydroxy-dg[tw] OR 8-hydroxy-guanine[tw] OR
8-hydroxy-2-deoxyguanosine[tw]) NOT ((“Child”[Mesh] OR “Infant”[Mesh] OR “Adolescent”[MeSH])
NOT “adult”[MeSH]) NOT (animals[mh] NOT humans[mh]).
4.2. Study Selection
The search was performed on 7 May 2019. Rayyan [103], a systematic review web application,
was used for title and abstract screening. We selected the studies in a stepwise process as depicted in
Figure 6. To be included in the analysis, a study had to be in English and to provide urinary 8-OHdG
concentrations in healthy adults (ages 18—no upper age limit) populations. We excluded non-human
studies, in vitro studies, reviews, letters, expert opinions, and editorials. We read the eligible articles in
depth, and only studies with original data from healthy (no known disease) adult populations were
included in the statistical analysis. All techniques used for the quantification of 8-OHdG were included
and classified accordingly. We excluded studies with coefficient variation <10% or >200%. We also
excluded data suspected to have unit or reported value mistakes (more than three orders of magnitude
higher than the median levels).
4.3. Data Extraction
We extracted the following information: first author name, publication year, study type, country,
analytic method, sample time, sample size, gender, mean age, mean BMI, smoking status, season,
occupation, pregnancy, diet, vitamin, exercise, outcome (8-OHdG concentration), references, and article
DOI. We extracted all subgroup-specific data when data on several subgroups were available in a given
paper. Then, we excluded all subgroups selected based on disease status (e.g., cardiovascular disease)
and all subgroups selected based on an exposure status (e.g., bus drivers). If data on the same subgroup
were reported for different times (e.g., different seasons), only the data at the time of participant
inclusion were included. In a third round, we excluded duplicate data (e.g., control population reported
in more than one study) and retained the most complete and the most recent study.
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4.4. Statistical Analysis
First, we analyzed the values of urinary 8-OHdG measured in original studies in view of
establishing the background ranges using meta-analysis. Measured values were generally log-normally
distributed. We therefore computed geometric means (GM) and geometric standard deviations (GSD)
as the basis for the meta-analysis or equivalently muL = ln(GM) and sdL = ln(GSD). Further details
on the data treatment and analyses are available elsewhere [104].
We could not compute standard errors on the geometric (or arithmetic) scale when neither standard
deviation (SD), GSD, IQR, nor confidence interval (CI) were reported. As a consequence, we excluded
these studies from the meta-analysis. We converted all the concentration values to the same units
(ng/mg creatinine) before computing GM and GSD. We used 113.12 g/mol for the molecular weight for
creatinine and 283.24 g/mol for 8-OHdG. We regrouped the data according to analytical techniques
used; immunological techniques and chemical techniques. The data were analyzed separately.
We followed standard practice in meta-analysis [105] and represent the data as forest plots
including the I-squared. This is an estimate of the between-study heterogeneity in percentage. If
the between-study heterogeneity is much larger than the between-subject heterogeneity, then I2 is large.
In this case, any attempt of obtaining a background value for individual participants will not be valid.
In our case, a mixed model with study ID as a random effect is a more relevant analysis model. This
yields results on the study subgroup level rather than at the individual level. Data management and
statistical analyses were performed in STATA version 16 software.
5. Conclusions
We report pooled GM values for urinary 8-OHdG in healthy adults, separately for chemical and
immunological methods. We observed a significant positive association between smoking status and
urinary 8-OHdG concentrations when measured by chemical analysis. No gender effect was shown.
Urinary 8-OHdG can potentially be used to quantify excess oxidative stress due to external exposures
when background values have been established in different populations. We recommend adjusting
urine samples with creatinine, quantifying 8-OHdG with chemical methods, and reporting results as
median and quartiles. Comparing values across studies will then be feasible.
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